Page last updated: 2024-11-06

thyroxine and Apolipoprotein B-100, Familial Defective

thyroxine has been researched along with Apolipoprotein B-100, Familial Defective in 13 studies

Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.

Research Excerpts

ExcerptRelevanceReference
" With initial values below 350 mg/100 ml the difference in the cholesterol decrease between the two dosage groups is not therapeutically relevant."6.65[Therapy of hyperlipoproteinemia type IIa and IIb with etiroxate-HCl. Dose-response comparison]. ( Banz, H; Gall, FP, 1979)
"Six female patients with a primary hyperlipoproteinemia type IIa received 40 mg/day etiroxate for 2 months."3.66Effects of etiroxate on low density and high density lipoproteins in hypercholesterolemic patients. ( Schwandt, P; Weisweiler, P, 1981)
" With initial values below 350 mg/100 ml the difference in the cholesterol decrease between the two dosage groups is not therapeutically relevant."2.65[Therapy of hyperlipoproteinemia type IIa and IIb with etiroxate-HCl. Dose-response comparison]. ( Banz, H; Gall, FP, 1979)
"The surgical treatment of hypercholesterolemia and the treatment of homozygous and other forms of hypercholesterolemia are also detailed."2.36Treatment of hypercholesterolemia. ( Kane, JP; Malloy, MJ, 1982)
" The high circulating levels of D-T4 and possibly of D-T3 after chronic administration of D-T4 may be responsible for the saturation of pituitary nuclear T3 receptors, resulting in the suppression of the TRH-induced TSH response."1.26Effects of dextrothyroxine on the pituitary-thyroid axis in hypercholesterolemic children and goitrous adults. ( Brun, LD; Coulombe, P; Dussault, JH; Gagné, C; Lupien, PJ; Moorjani, S, 1980)

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-199010 (76.92)18.7374
1990's1 (7.69)18.2507
2000's1 (7.69)29.6817
2010's1 (7.69)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Paja Fano, M1
Egaña Zunzunegui, N1
Lizarraga Zufiaurre, A1
Elorza Olabegoya, R1
Rivero, M1
Otermin, I1
Pereda, A1
Cía, M1
Martínez, M1
Thompson, GR1
Soutar, AK1
Spengel, FA1
Jadhav, A1
Gavigan, SJ1
Myant, NB1
Kolodin, VA1
Gasilin, VS1
Baranov, VA1
Antonov, IuS1
Dokuchaeva, EA1
Brun, LD1
Gagné, C1
Coulombe, P1
Lupien, PJ1
Dussault, JH1
Moorjani, S1
Kane, JP1
Malloy, MJ1
Zadák, Z1
Kalinová, M1
Sobotka, L1
Weisweiler, P1
Schwandt, P1
Banz, H2
Gall, FP2
Kuklinski, B1
Titlbach, O1
Kellner, K1
Benvenga, S1
Robbins, J1
Nakao, S1
Ueda, M1
Yamashita, S1
Matsuzawa, Y1
Harada, M1
Matsuda, T1

Reviews

1 review available for thyroxine and Apolipoprotein B-100, Familial Defective

ArticleYear
Treatment of hypercholesterolemia.
    The Medical clinics of North America, 1982, Volume: 66, Issue:2

    Topics: Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Heterozygote; Homozygote; Humans; Hyper

1982

Trials

2 trials available for thyroxine and Apolipoprotein B-100, Familial Defective

ArticleYear
[Dose-response comparison with etiroxat HCl in hyperlipoproteinemias types IIa and IIb].
    Medizinische Klinik, 1980, Jan-04, Volume: 75, Issue:1

    Topics: Anticholesteremic Agents; Dose-Response Relationship, Drug; Female; Humans; Hyperlipoproteinemia Typ

1980
[Therapy of hyperlipoproteinemia type IIa and IIb with etiroxate-HCl. Dose-response comparison].
    Fortschritte der Medizin, 1979, Nov-08, Volume: 97, Issue:42

    Topics: Cholesterol; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Hyperlipoproteinemia

1979

Other Studies

10 other studies available for thyroxine and Apolipoprotein B-100, Familial Defective

ArticleYear
[Isolated adult thyrotropin deficiency. An unusual finding of unknown etiology].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57, Issue:8

    Topics: Adenoma; Adult; Age of Onset; Asthenia; Congenital Hypothyroidism; Humans; Hyperlipoproteinemia Type

2010
[Musculoskeletal adverse effects of levofloxacin].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2006, Volume: 19, Issue:4

    Topics: Anti-Bacterial Agents; Arthralgia; Arthritis; Arthritis, Infectious; Arthroplasty, Replacement, Knee

2006
Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo.
    Proceedings of the National Academy of Sciences of the United States of America, 1981, Volume: 78, Issue:4

    Topics: Biological Transport; Homozygote; Humans; Hyperlipoproteinemia Type II; Hypothyroidism; Lipoproteins

1981
[Role of excessive body weight and hormonal changes in the development of the main types of hyperlipoproteinemia].
    Kardiologiia, 1984, Volume: 24, Issue:11

    Topics: Adrenocortical Hyperfunction; Adult; Growth Hormone; Humans; Hydrocortisone; Hyperinsulinism; Hyperl

1984
Effects of dextrothyroxine on the pituitary-thyroid axis in hypercholesterolemic children and goitrous adults.
    The Journal of clinical endocrinology and metabolism, 1980, Volume: 51, Issue:6

    Topics: Adult; Animals; Child; Dextrothyroxine; Female; Goiter; Humans; Hyperlipoproteinemia Type II; Male;

1980
[Etiroxate treatment for hyperlipoproteinaemia type IIa and IIb (author's transl)].
    Casopis lekaru ceskych, 1982, May-14, Volume: 121, Issue:19

    Topics: Adult; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Male; Thyroxine

1982
Effects of etiroxate on low density and high density lipoproteins in hypercholesterolemic patients.
    Atherosclerosis, 1981, Volume: 39, Issue:1

    Topics: Adult; Apolipoproteins; Cholesterol; Female; Humans; Hyperlipoproteinemia Type II; Lipoproteins, HDL

1981
[Modification of thyroid hormones by unsaturated fatty acid after noradrenaline load].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1980, May-15, Volume: 35, Issue:10

    Topics: Adult; Dietary Fats; Fatty Acids, Unsaturated; Helianthus; Humans; Hyperlipoproteinemia Type II; Mal

1980
Enhancement of thyroxine entry into low density lipoprotein (LDL) receptor-competent fibroblasts by LDL: an additional mode of entry of thyroxine into cells.
    Endocrinology, 1990, Volume: 126, Issue:2

    Topics: Cell Line; Fibroblasts; Humans; Hyperlipoproteinemia Type II; Kinetics; Lipoproteins, LDL; Prealbumi

1990
[A case of familial hypercholesterolemia associated with Basedow's disease].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1987, Volume: 76, Issue:6

    Topics: Adult; Graves Disease; Humans; Hyperlipoproteinemia Type II; Male; Probucol; Thyroxine; Triiodothyro

1987